NCT06202040

Brief Summary

The respiratory system receives mechanical power (MP) throughout time during mechanical ventilation. Despite its life-saving benefits, mechanical ventilation can cause ventilator-induced lung injury (VILI). Recently, VILI has been linked to mechanical power, or the amount of energy the mechanical ventilator sends to the respiratory system in a given time. The hunt for lung damage-reducing characteristics, notably after VILI and ARDS (Acute respiratory distress syndrome), has increased after Covid-19. Mechanical power must be used more to promote lung protection. We examined the effects of bilateral rectus sheath and OSTAP (Oblique Subcostal Transversus Abdominis Plane ) block on mechanically powered patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

December 22, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2024

Completed
Last Updated

May 23, 2024

Status Verified

May 1, 2024

Enrollment Period

24 days

First QC Date

December 21, 2023

Last Update Submit

May 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • mechanical power will be calculated from these measurements (mec power 1, mec power 2, mec power 3) as a joule.

    Primary outcome measures will be based on intraoperative measurements taken from the mechanical ventilator, and mechanical power will be calculated from these measurements (mec power 1, mec power 2, mec power 3).

    Comen after intubation (before the block procedure), end of the surgery pre sugammadex administration and end of the surgery post sugammadex administration

Secondary Outcomes (3)

  • Visual Analog Scale (VAS) for pain evaluation (0-10, 0 = no pain, 10 = the most severe pain).

    postoperative assessments at 30 minutes, 2 hours, 8 hours, and 24 hours

  • the Quality of Recovery-15 Test (QoR-15T) [ Excellent (QoR-15 > 135 point), Good (122 ≤ QoR-15 ≤ 135 points), Moderate (90 ≤ QoR-15 ≤ 121 point), Poor (QoR-15 < 90 points) ]

    Postoperative assessments at 24 hours

  • Number of rescue analgesic needs

    Postoperative assessments at 30 minutes, 2 hours, 8 hours, and 24 hours

Study Arms (2)

Group 1:OSTAPand RSB

ACTIVE COMPARATOR

Group 1 will consist of patients who received general anesthesia, and just before the surgery started, bilateral OSTAP and RSB will be performed.

Procedure: Bilateral Oblique Subcostal Transversus Abdominis Plane Block (OSTAP) will be performed.Procedure: Bilateral Rectus Sheath Block (RSB) will be performed.

Group 2: Intravenous analgesia

NO INTERVENTION

Group 2 will include patients who received general anesthesia and were administered intravenous analgesia approximately 30 minutes before the end of the operation.

Interventions

The OSTAP block will be conducted in-plane using a 100mm 22 G needle and a linear probe under ultrasound (USG) guidance. The 20cc block will contain 10cc of 0.5% bupivacaine and 10cc of normal saline. Bilateral OSTAP will be administered with 20cc (10cc per side). To apply the block, position the linear probe parallel to the rib edge immediately below it on the anterior abdominal wall. Visible will be the external, internal, transversus abdominis, and rectus muscle junction. The needle tip will move toward the TAP space (between the internal oblique and transversus abdominis muscles). To ensure medication delivery, the needle tip will be visible in the TAP and the drug will be aspirated negatively. USG will also observe drug distribution at the rectus abdominis muscle-TAP space junction.

Group 1:OSTAPand RSB

When the patient is in the supine position, the ultrasound (USG) linear probe is held in the transverse plane at the level just above the umbilicus, where the posterior rectus sheath is best visualized. Using the in-plane technique with a 100mm 22 G needle under USG guidance, the drug prepared will be administered between the rectus muscle and the posterior rectus sheath. For this block, a volume of 20cc will be prepared, consisting of 10cc of 0.5% bupivacaine and 10cc of normal saline. Bilateral Rectus Sheath Block (RSB) will be applied with a total volume of 20cc, 10cc to each side.

Group 1:OSTAPand RSB

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 65 years
  • ASA 1-2 patients
  • Patients undergoing elective laparoscopic cholecystectomy

You may not qualify if:

  • Mental retardation,
  • Severe presence of COPD,
  • Uncontrolled Bronchial Asthma,
  • Decompensated Heart Failure (NYHA 3-4),
  • History of previous lung surgery,
  • Patients unwilling to participate in the study,
  • Local anesthetic allergy,
  • History of chronic pain and treatment,
  • Morbid obesity (body mass index (BMI) \>35),
  • Pregnancy,
  • Patients converted to open cholecystectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya Cıty Hospıtal

Konya, 42020, Turkey (Türkiye)

Location

Related Publications (1)

  • Karaarslan E, Tire Y, Tutar MS, Akinci N, Mermer HA, Uyar S, Ates D, Simsek G, Kozanhan B. The effect of bilateral rectus sheath and oblique subcostal transversus abdominis plane blocks on mechanical power in patients undergoing laparoscopic cholecystectomy surgery: a randomized controlled trial. BMC Anesthesiol. 2025 Apr 16;25(1):186. doi: 10.1186/s12871-025-03062-6.

Study Officials

  • Esma Karaarslan, MD

    Konya City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 11, 2024

Study Start

December 22, 2023

Primary Completion

January 15, 2024

Study Completion

January 25, 2024

Last Updated

May 23, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Maybe, we can share all info after finish the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
We want to descrıbe time frame after finish the study.
Access Criteria
We can share the data by usın e-mail.

Locations